Pfizer executives may have deliberately slowed COVID-19 vaccine testing to avoid influencing the 2020 presidential election in favor of Trump, according to explosive new allegations being investigated by Congress.
Key Takeaways
- The GOP-led House Judiciary Committee is investigating claims that Pfizer intentionally delayed COVID-19 vaccine test results until after the 2020 election
- Former Pfizer executive Philip Dormitzer allegedly told colleagues that “the three most senior people in Pfizer R&D” were involved in deliberately slowing clinical testing
- Dormitzer reportedly requested relocation to Canada over fears of being investigated by the Trump administration
- President Trump has maintained that earlier vaccine announcement could have benefited his re-election campaign
- Pfizer denies political interference, insisting their timeline was driven by scientific and regulatory protocols
Congressional Investigation Underway
House Judiciary Committee Chair Jim Jordan has launched a formal investigation into troubling allegations that pharmaceutical giant Pfizer purposely delayed COVID-19 vaccine testing to prevent the results from influencing the 2020 presidential election. The committee is examining claims that Pfizer’s leadership made a calculated decision to slow down clinical trials, potentially impacting a pivotal moment in American politics during the pandemic. These serious accusations suggest that pharmaceutical executives may have manipulated the timing of vital public health information for political purposes rather than scientific necessity.
The investigation centers around statements allegedly made by Dr. Philip Dormitzer, a former senior Pfizer scientist who later worked at GlaxoSmithKline (GSK). According to information provided to the committee, Dormitzer told GSK colleagues that Pfizer’s research and development leadership intentionally delayed the vaccine timeline. Committee documents indicate Dormitzer claimed “the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
“Let’s just say it wasn’t a coincidence, the timing of the vaccine” Said Philip Dormitzer
Dormitzer’s Canada Relocation Request
Perhaps most damning in the allegations is Dormitzer’s reported request to relocate to Canada after Trump won the 2024 election. According to testimony provided to investigators, Dormitzer displayed significant anxiety about potential repercussions from the Trump administration over his role in the vaccine development process. This fear apparently led to an explicit request for international relocation to avoid scrutiny from American authorities, raising serious questions about consciousness of guilt.
“As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine” Stated Jordan
Pfizer’s Response and Denials
Pfizer has categorically denied any political interference in its vaccine development timeline. The pharmaceutical giant maintains that its processes were guided solely by scientific protocols and regulatory requirements, not political calculations. The company has agreed to respond directly to the committee’s inquiries but has not yet provided substantive explanations for the allegations. Dormitzer himself has attempted to walk back the statements attributed to him, claiming his comments were misinterpreted.
“My Pfizer colleagues and I did everything we could to get the FDA’s Emergency Use Authorization at the very first possible moment. Any other interpretation of my comments about the pace of the vaccine’s development would be incorrect” Stated Dr. Philip Dormitzer
The company’s spokeswoman Amy Rose confirmed receipt of the committee’s letter, stating simply that Pfizer “would respond directly to the committee.” This measured response has done little to quell suspicions among conservatives who have long questioned the timing of the vaccine announcement, which came just days after the 2020 election results were called for Biden. The proximity of these events has fueled persistent concerns about potential interference in the democratic process through manipulation of vital health information.
Trump’s Vindication
President Trump has consistently maintained that Pfizer intentionally withheld positive trial results that could have benefited his 2020 campaign. The allegations now being investigated appear to validate these claims, suggesting that pharmaceutical executives may have manipulated public health information to influence American politics. The timing was particularly suspicious – Pfizer announced its vaccine’s 90% effectiveness on November 9, 2020, just two days after major media outlets called the election for Biden.
The House Judiciary Committee’s investigation continues to gather documents and testimony from key figures involved. Chair Jim Jordan has formally requested records and communications from both Dormitzer and Pfizer CEO Albert Bourla. The Wall Street Journal reported that federal prosecutors are also investigating a tip from GSK regarding these allegations. As the investigation unfolds, many conservatives are questioning whether this represents yet another example of corporate interference in democratic processes aimed at undermining President Trump’s administration.
